Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 22.95 billion as of May 12, 2025. Its market cap has decreased by -11.15% in one year.

Market Cap

22.95B

Enterprise Value

23.76B

Revenue

4.62B

Ranking

n/a

PE Ratio

1.00

Stock Price

10.58

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 22.95B, an increase of 986.58%. That is a compound annual growth rate of 28.99%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	22.95B	8.78%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	194.78B
Hansoh Pharmaceutical Group Company	140.92B
JD Health International	117.99B
WuXi Biologics	91.59B
Innovent Biologics	86.36B
Alibaba Health Information Technology	80.09B
Akeso	75.71B
Sichuan Kelun-Biotech Biopharmaceutical	71.46B

Market Cap Rankings